Search results
Daphne Koller is CEO and founder of insitro, a machine learning-driven drug discovery and development company transforming the way drugs are discovered and delivered to patients. She was the co-founder, co-CEO, and president of online education platform Coursera, the largest platform for massive open online courses (MOOCs), which has reached ...
View Daphne Koller’s profile on LinkedIn, a professional community of 1 billion members. For most of my career, I've been working at the boundary of two disciplines: machine…
- 500+
- 15K
- insitro
- San Francisco Bay Area
People also ask
Who is Daphne Koller?
Will Insitro overturn how drugs get discovered?
Who has the energy to work at Insitro?
What does Insitro do if a bioengineering experiment fails?
Oct 25, 2023 · Koller explained a two-step process that can lead to novel drug targets for cancer. In the first step, Insitro machine learning AI technology is able to analyze images of cancerous tissue, a ...
Articles 1–20. CEO and Founder, insitro - Cited by 111,095 - machine learning - computational biology - computer vision - artificial intelligence.
San Francisco Ballet discusses artificial intelligence with Daphne Koller. Daphne Koller is a Machine Learning pioneer and the founder and CEO of insitro, a biotech company that leads AI-driven drug discovery. She is also the co-founder of the online learning platform Coursera, and was a professor in the department of computer science at ...
Sep 17, 2019 · The ex-Stanford University computer science professor, MacArthur Fellow and cofounder of online education unicorn Coursera created Insitro to completely rethink the expensive, time-intensive drug...
Nov 11, 2019 · Can a giant pile of data beat human expertise in the design of miracle drugs? Daphne Koller and her startup Insitro may come up with a surprising answer.
